Journal
FREE RADICAL BIOLOGY AND MEDICINE
Volume 100, Issue -, Pages 175-181Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2016.04.025
Keywords
Mitochondria; Cancer; Oncometabolites; FH; SDH; IDH; Fumarate; Succinate; 2-Hydroxyglutarate
Funding
- MRC
- Medical Research Council [MC_UU_12022/6] Funding Source: researchfish
- MRC [MC_UU_12022/6] Funding Source: UKRI
Ask authors/readers for more resources
Cancer is a complex and heterogeneous disease thought to be caused by multiple genetic lesions. The recent finding that enzymes of the tricarboxylic acid (TCA) cycle are mutated in cancer rekindled the hypothesis that altered metabolism might also have a role in cellular transformation. Attempts to link mitochondrial dysfunction to cancer uncovered the unexpected role of small molecule metabolites, now known as oncometabolites, in tumorigenesis. In this review, we describe how oncometabolites can contribute to tumorigenesis. We propose that lesions of oncogenes and tumour suppressors are only one of the possible routes to tumorigenesis, which include accumulation of oncometabolites triggered by environmental cues. (C) 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available